employee
Moscow, Moscow, Russian Federation
Moscow, Moscow, Russian Federation
Alikov, Moscow, Russian Federation
Moscow, Moscow, Russian Federation
employee
Moscow, Moscow, Russian Federation
UDC 616.31
Relevance. Modern dental implantology has achieved significant success, but patients with metabolic disorders, especially type 2 diabetes mellitus (T2DM), are still a complex category characterized by a high risk of developing osseointegration disorders and postoperative complications. In such patients, there is a decrease in osteogenic potential, deterioration of regenerative processes and increased bone resorption. In this regard, an urgent task is to find and implement additional methods that help improve osseointegration. One of the promising directions is considered to be the use of chondroitin sulfate, a natural biopolymer with proven osteotropic, anti-inflammatory and regenerative properties capable of stimulating bone metabolism and improving the microenvironment in the implantation area. Aim. To conduct a clinical evaluation of the effectiveness of the combined use of chondroitin sulfate (systemic and local) in dental implantation in patients with DM2 and signs of reduced osteogenic potential. Materials and methods. The study included 72 patients with a verified diagnosis of DM2 and signs of osteopenia (type D3–D4 according to the Misch classification). The participants were divided into three groups: O1 — combined use of chondroitin sulfate (oral and topical), O2 — systemic therapy only, K — control group without chondroitin sulfate. Over the course of 12 months, hygienic and periodontal status, ISQ indices, bone density (in HU), and marginal resorption were assessed using RFA, CBCT, and visiography techniques. Results. The O1 group showed the best clinical results: an increase in ISQ was +16.91%, bone density increased by 18.3%, and marginal bone resorption was minimal — 0.10 mm. The implant survival rate was 100% in the experimental groups and 95.8% in the control group. The developed protocol confirmed its high clinical efficacy and osteoprotective effect.
dental implantation, chondroitin sulfate, glycosaminoglycans, diabetes mellitus, osseointegration, digital dentistry
1. Al-Rafee M.A. The epidemiology of edentulism and the associated factors: A literature Review. - Review J Family Med Prim Care. – 2020; 30 9(4): 1841-1843. PMID: 32670928.
2. Jeyapalan V. Partial Edentulism and its Correlation to Age, Gender, Socio-economic Status and Incidence of Various Kennedy's Classes - A Literature Review. - Review J Clin Diagn Res. – 2015; 9(6): 14-17. PMID: 26266237.
3. Bhochhibhoya A., Rana S.B., Sharma R. Impact of sociodemographic factors, duration of edentulism, and medical comorbidities on the mental attitudes of individuals with complete edentulism. - J Prosthet Dent. – 2021; 18; 217-221. eLIBRARY ID: 57838172.
4. Reich KM, Huber CD, Lippnig WR, Ulm C, Watzek G, Tangl S. Atrophy of the residual alveolar ridge following tooth loss in an historical population. - Oral Dis. - 2011; 17(1): 33-44. PMID: 20604872.
5. Zaidi M. Skeletal remodeling in health and disease. - Review Nat Med. – 2007; 13(7): 791-801. – PMID: 17618270.
6. Diaz-Suarez L. An overview of modern concepts of complete rehabilitation of the arch using dental implants. - Reviewed. - 2021. http://dx.doi.org/10.5772/intechopen.99704
7. Saghiri M.A., Freag P., Fakhrzadeh A. et al. Current technology for identifying dental implants: a narrative review. - Bull Natl Res Cent. - 2021; 45: 7. https://doi.org/10.1186/s42269-020-00471-0
8. Aver'yanov S.V., Kamilov F.H., Yunusov R.R. Vzaimosvyaz' funkcional'nogo sostoyaniya schitovidnoy zhelezy, mineral'noy plotnosti kostnoy tkani skeleta i pokazateley stomatologicheskogo statusa pacientov. - Dental Forum. – 2020; 1(76): 2-8. [Averyanov S.V., Kamilov F.H., Yunusov R.R. Interrelation of the functional state of the thyroid gland, bone mineral density of the skeleton and indicators of the dental status of patients. - Dental Forum. – 2020; 1(76): 2-8. (In Russian)]. eLIBRARY ID: 42194426.
9. Gibreel S., Mohammed H.K., Suraj A.R., Anil S. Osteointegration of dental implants and osteoporosis. - Reviewed. – 2021. DOI:https://doi.org/10.5772/intechopen.100270.
10. Wagner J., Spille J.H., Wiltfang J., Naujokat H. Systematic review on diabetes mellitus and dental implants: an update. - Review Int. J. Implant Dent. – 2022; 3; 8(1): 1. PMID: 34978649.
11. Jiang X., Zhu Y., Liu Z. Association between diabetes and dental implant complications: a systematic review and meta-analysis. - Acta Odontol. Scand. – 2021; 79(1): 9-18. PMID: 32401121.
12. Torrejon-Maya A., Izquierdo-Gomez K., Perez-Sayans M. Patients with Thyroid Disorder, a Contraindication for Dental Implants? A Systematic Review. - Review J Wedge Honey. – 2022; 25; 11(9): 2399. PMID: 35566524.
13. Pal D, Saha S. Chondroitin: a natural biomarker with immense biomedical applications. - RSC Adv. - 2019 (6); 9(48): 28061-28077. PMID: 35530463.
14. Mazukina E.V., Shekunova E. V., Kosman V.M. Izuchenie effektivnosti i bezopasnosti preparata hondroitin sul'fat v doklinicheskih issledovaniyah. - Bezopasnost' i risk farmakoterapii. – 2021; 1: 43-57. [Mazukina E.V., Shekunova E. V., Kosman V.M. Studying the efficacy and safety of the drug chondroitin sulfate in preclinical studies. - Safety and risk of pharmacotherapy. – 2021; 1: 43-57. (In Russian)]. eLIBRARY ID: 44835119.
15. Rammelt S., Heck, R. Bernhardt In vivo effects of coating loaded and unloaded Ti implants with collagen, chondroitin sulfate, and hydroxyapatite in the sheep tibia. - J Orthop Res. – 2007; 25(8): 1052-1061. PMID: 17457829.
16. Korn P., Schulz M.C., Hintze V. Chondroitin sulfate and sulfated hyaluronan-containing collagen coatings of titanium implants influence peri-implant bone formation in a minipig model. - J Biomed Mater Res A. – 2014; 102(7): 2334-2344. PMID: 23946280.
17. Lamari F.N., Theocharis A.D., Asimakopoulou A.P., Malavaki C.J., Karamanos N.K. Metabolism and biochemical/physiological roles of chondroitin sulfates: analysis of endogenous and supplemental chondroitin sulfates in blood circulation. - Biomed Chromatogr. 2006; 20(6-7): 539-50. PMID: 16779785.
18. Kovaleva M.A., Guschin Ya.A. Aprobaciya modeli hronicheskogo osteoartroza na krolikah. - Laboratornye zhivotnye dlya nauchnyh issledovaniy. – 2019; 4: 3. [Kovaleva M.A., Gushchin Ya.A. Approbation of a model of chronic osteoarthritis in rabbits. - Laboratory animals for scientific research. – 2019; 4: 3. (In Russian)]. DOI https://doi.org/10.29296/2618723X-2019-04-03
19. Dudeck J., Rehberg S., Bernhardt R. Increased bone remodelling around titanium implants coated with chondroitin sulfate in ovariectomized rats. - Acta Biomater. – 2014; (6): 2855-2865. PMID: 24534718.
20. Bykova N.I., Odol'skiy A.V., Grigoryan V.A. Eksperimental'noe obosnovanie primeneniya glyukozamina gidrohlorida i hondroitina sul'fata pri zabolevaniyah parodonta. - Medicinskiy vestnik Severnogo Kavkaza. – 2017; 2: 195-198. [Bykova N.I. Podolsky A.V., Grigoryan V.A. Experimental substantiation of the use of glucosamine hydrochloride and chondroitin sulfate in periodontal diseases. - Medical Bulletin of the North Caucasus. – 2017; 2: 195-198. (In Russ.)]. DOI https://doi.org/10.14300/mnnc.2017.12054
21. Stepanov A. G., Apresyan S. V., Alikov M. H., Yudin L. P., Kancerova L. R. Vliyanie hondroitina sul'fata pri vnutri myshechnom vvedenii na reparativnyy osteogenez v eksperimente in vivo. — Klinicheskaya stomatologiya. — 2024; 27 (4): 122—130. [Stepanov A.G., Apresyan S.V., Alikov M.Kh., Yudin L.P., Kancerova L.R. The effect of chondroitin sulfate on reparative osteogenesis in an in vivo experiment. — Clinical Dentistry. — 2024; 27 (4): 122—130. (In Russ.)]. https://doi.org/10.37988/1811-153X_2024_4_122.
22. Cheng K., Zhu Y., Wang D.Q. Biomimetic synthesis of chondroitin sulfate-analogue hydrogels for regulating osteogenic and chondrogenic differentiation of bone marrow mesenchymal stem cells. - Mater Sci Eng C Mater Biol Appl. – 2020; 111368. PMID: 32919697.
